Gyre Therapeutics, Inc. Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 97.24%71.07%-0.57%46.98%95.91%96.33%
EBT Margin -157.58%16.83%-8.74%-12.27%-8,928.87%-1,607.23%-844.80%-4,246.87%-2,117.98%-500,916.67%787,700.00%-268.91%-1,198.32%9.20%-67.84%21.95%
EBIT Margin -160.90%15.30%-9.98%-14.06%-1,934.99%-414.18%-788.69%-5,117.29%-2,143.61%-563,700.00%818,242.86%-273.87%-1,197.79%9.00%-59.26%15.28%
EBITDA Margin -160.90%12.98%-8.93%-11.81%-8,952.01%-1,803.97%-788.69%-5,117.29%-2,143.61%-563,700.00%818,242.86%-273.87%-1,197.79%9.00%-59.26%15.28%
Operating Margin -160.90%15.30%-9.98%-14.06%-1,934.99%-414.18%-788.69%-5,117.29%-2,143.61%-563,700.00%818,242.86%-273.87%-1,197.79%9.00%-59.26%15.28%
Net Margin -157.23%12.72%-8.74%-12.09%-8,930.21%-1,799.39%-844.80%-4,246.87%-2,506.09%-500,916.67%788,257.14%-268.48%-1,198.32%2.25%-81.92%11.43%
FCF Margin -97.64%157.49%-87.21%-111.60%-1,207.46%-352.62%-1,108.00%-4,746.87%-1,961.00%-482,150.00%623,957.14%-262.78%-1,152.82%5.56%15.32%-5.63%
Efficiency
Inventory Average 5.20M5.31M
Assets Average 260.46M223.85M167.73M74.43M36.25M53.81M38.80M82.22M75.25M70.21M100.65M120.97M
Equity Average 63.18M80.42M133.07M40.47M-98.17M-106.18M-38.96M23.75M23.53M75.46M58.58M56.65M28.19M41.29M
Invested Capital 70.43M93.56M175.53M-92.49M-102.16M-109.35M32.58M16.07M30.98M119.94M76.07M41.09M72.22M-15.83M98.40M
Asset Utilization Ratio 0.370.260.000.020.050.010.030.000.101.461.130.87
Leverage & Solvency
Interest Coverage Ratio -185.8385.72-73.83-94.63-190.94-326.48-9.20-0.01M-630.446.70-25.92
Debt to Equity 0.050.030.02-0.02-0.010.04
Debt Ratio 0.010.010.010.010.02
Equity Ratio 0.350.68-0.49-0.71-36.680.450.420.780.960.800.740.85-0.140.78
Times Interest Earned -185.8385.72-73.83-94.63-190.94-326.48-9.20-0.01M-630.446.70-25.92
Dividends & Payouts
FCF Payout Ratio 7.91
Valuation
Enterprise Value 467.89M545.27M-9.06M101.07M99.02M88.42M3.27M-48.20M3.19M-113.74M82.00M8.55M-20.65M21.13M61.31M1,139.98M
Market Capitalization 578.95M759.29M185.95M147.19M139.69M90.24M35.77M7.82M58.80M94.23M82.00M139.44M28.71M16.61M65.04M1,131.61M
Return Ratios
Return on Sales -1.57%0.13%-0.09%-0.12%-89.30%-17.99%-8.45%-42.47%-21.18%-2.69%-11.98%0.03%-0.76%0.16%
Return on Capital Employed -0.05%-0.04%-0.06%-0.10%9.17%-0.64%-0.73%-0.44%-1.44%0.16%-0.83%0.16%
Return on Invested Capital -0.62%0.12%-0.19%0.06%0.28%
Return on Assets -0.03%-0.03%-0.28%-0.44%-0.41%-0.31%-0.56%-0.37%-1.17%0.05%-0.86%0.14%
Return on Equity -0.62%0.14%-0.06%-0.17%0.48%0.31%0.38%-0.71%-0.92%-0.40%-1.50%0.06%-3.06%0.41%